Total consumption of antibacterials for systemic use J01 |
Combinations of penicillins including β‐lactamases, 2nd‐ and 3rd‐generation cephalosporins, carbapenems and fluoroquinolones |
Ratio of the consumption of broad‐spectrum penicillins, cephalosporins, macrolides and fluoroquinolones (J01(CR+DC+DD+(F‐FA01)+MA)) to the consumption of narrow‐spectrum penicillins, cephalosporins and macrolides (J01(CE+DB+FA01)) |
Macrolides (except erythromycin) J01FA (−J01FA01) |
Carbapenems J01DH |
Glycopeptides, 3rd‐ and 4th‐generation cephalosporins, monobactams, carbapenems, fluoroquinolones, polymyxins, piperacillin and enzyme inhibitor, linezolid, tedizolid, daptomycin |
Initial list of proposed indicators (AMR)
|
Escherichia coli resistant to 3rd‐generation cephalosporins |
Meticillin‐resistant Staphylococcus aureus
|
Streptococcus pneumoniae resistant to macrolides |
Streptococcus pneumoniae resistant to penicillin |
Salmonella Enteritidis resistant to 3rd‐generation cephalosporins |
Campylobacter spp. resistant to fluoroquinolones |
Escherichia coli resistant to aminoglycosides, fluoroquinolones and 3rd‐generation cephalosporins |
Klebsiella pneumoniae resistant to carbapenems |
Klebsiella pneumoniae resistant to aminoglycosides, fluoroquinolones and 3rd‐generation cephalosporins |
Pseudomonas aeruginosa resistant to three or more antimicrobial groups among piperacillin + tazobactam, ceftazidime, fluoroquinolones, aminoglycosides and carbapenems |
Acinetobacter baumannii resistant to carbapenems |
Enterococcus faecium resistant to vancomycin |